NCT04950283View on ClinicalTrials.gov

MR-based Characterization of Bone Marrow in Its Relevance to Skeletal Disease in Patients With Diabetes

Active, not recruitingOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

April 25, 2023

Study Completion Date

December 31, 2024

Conditions
Diabetes Mellitus, Type 2OsteoporosisInsulin Resistance
Interventions
DIAGNOSTIC_TEST

magnetic resonance examination, anthropometric and metabolic characterization

Participants undergo a magnetic resonance examination, anthropometric characterization and metabolic characterization via oral glucose tolerance test.

Trial Locations (1)

72076

University Hospital, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER